Asymmetric dimethylarginine (ADMA) a novel cardiovascular risk factor - evidence from epidemiological and prospective clinical trials.
Journal Title: Pharmacological Reports - Year 2006, Vol 58, Issue 0
Abstract
There is a growing clinical evidence to support the hypothesis that asymmetric dimethylarginine (ADMA), an endogenous inhibitor of nitric oxide synthase is a new independent cardiovascular risk factor. ADMA mediates endothelial dysfunction in lipid disorders, coronary artery disease, chronic heart failure, diabetes mellitus and hypertension. The aim of this review was to summarize the latest evidence from epidemiological and prospective clinical trials and to emphasize the role of ADMAas a cardiovascular risk factor.
Authors and Affiliations
Andrzej Szuba, Maciej Podgórski
Keywords
Related Articles
- EP ID EP96570
- DOI -
- Views 94
- Downloads 0
Puerarin inhibits iNOS, COX-2 and CRP expression via suppression of NF-κB activation in LPS-induced RAW264.7 macrophage cells.
Puerarin (7,4'-dihydroxy-8-C-glucosylisoflavone) is the most abundant isoflavone-C-glucoside extracted from Radix puerariae, and it has been used for various medicinal purposes in traditional oriental medicine for thousa...
Adaptive vasoactive response to modulatory effects of endothelin-1 in spontaneously hypertensive rats.
In addition to a direct vasoconstrictor effect, endothelins modulate vascular responses induced by different mediators.We compared the effect of subthreshold concentrations of endothelin-1 (ET) on vasoreactivity of isola...
Effect of two behavioral tests on corticosterone level in plasma of mice lacking the noradrenaline transporter.
In the present study, we investigated plasma corticosterone levels of genetically modified mice lacking noradrenaline transporter (NET(-/-)), in response to the forced swim test (FST) and tail suspension test (TST). FST...
Hypotensive effect of atorvastatin is not related to changes in inflammation and oxidative stress.
We sought to determine if atorvastatin lowers blood pressure in patients with previously diagnosed and well-controlled essential arterial hypertension and if this effect could be related to anti-inflammatory and anti-oxi...
Role of silent polymorphisms within the dopamine D1 receptor associated with schizophrenia on D1-D2 receptor hetero-dimerization.
Within the coding region of the dopamine D(1) receptor (D(1)R), two synonymous polymorphisms, D(1)R(G198A) and D(1)R(G1263), have been identified and postulated to correlate with the schizophrenia phenotype. Binding stud...